Embed Size (px)
DESCRIPTION
According to Azoth Analytics research report, “Global Alzheimer’s Drug Market. For detailed info, mail: [email protected]
Citation preview
(c) AZOTH Analytics December 2015
Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020)
1
(c) AZOTH Analytics
Table of ContentFigure No. Title Page No.
1 Research Methodology2 Alzheimer’s Disease Market Overview3 Global Alzheimer’s Disease Market Outlook4 Global Alzheimer’s Disease Market
4.1 By Therapeutics4.2 By Diagnostics and Biomarkers 4.3 By Imaging Sector 4.4 By Disease Modifying Therapeutics
5 Global Alzheimer’s Disease Market Outlook-By Demographic (Age-Group) 6 Global Alzheimer’s Disease Market Outlook-By Drug6 Global Alzheimer’s Disease Market Outlook-By Region7 United States Alzheimer’s Disease Market Outlook
7.1 United States Dementia Market Outlook8 Global Dementia Disease Market Outlook9 Global Dementia Disease Market Outlook,
9.1 By Regional Break-Up9.1.1 Asia-Pacific Dementia Market Outlook
9.1 By Countries9.2.2 Low Income Country -wise Break up9.2.3 Top Ten Country-wise Break-Up
2
(c) AZOTH Analytics
Table of ContentFigure No.
Title Page No.
9.3 Australia Dementia Market Outlook 9.4 UK Dementia Market Outlook
10 Market Dynamics10.1 Drivers10.2 Challenges
11 Market Trends & Developments12 Competitive Landscape
12.2 Sales Comparatives, Top 5 Companies12.3 EBITDA Comparatives, Top 5 Companies12.4 EBIT Comparatives, Top 5 Companies12.5 PBT Comparatives, Top 5 Companies12.6 PAT Comparatives, Top 5 Companies12.7 Current Ratio Comparatives, Top 5 Companies
12 Company ProfilingPfizer Inc.Novartis International AGAxovant Sciences Ltd.Acadia PharmaceuticalsBiotie Therapies
3
(c) AZOTH Analytics
Table of ContentFigure No.
Title Page No.
12.8 Profit Margin Ratio Comparatives, Top 5 Companies12.9 Debt-Equity Ratio Comparatives, Top 5 Companies
13 About Us & Disclaimer
4
(c) AZOTH Analytics
List of FiguresFigure No. Title Page No.Figure 1: Global Alzheimer’s Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million)
2010-2020FFigure 2: Global Alzheimer’s Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
Figure 3: Global Alzheimer’s Market share, By TherapeuticsFigure 4: Global Alzheimer’s Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)Figure 5: Global Alzheimer’s Disease Market, By Imaging Sector, By Value (USD Million)x`Figure 6: Global Alzheimer’s Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD
Million)Figure 7: Global Alzheimer’s Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in
million),2010-2020FFigure 8: Global Alzheimer’s Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in
million),2010-2020FFigure 9: Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in
Million) 2010-2020FFigure 10: United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In
Million) 2010-2020FFigure 11: Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14Figure 12: U.S. Alzheimer’s Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)Figure 13: U.S. Alzheimer’s Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)Figure 14: U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013Figure 15: U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013
5
(c) AZOTH Analytics
List of FiguresFigure No. Title Page No.Figure 16: Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million)
2010-2020FFigure 17: Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014Figure 18: Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In
Million), By Region 2014Figure 19: Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country
2015E,2030F,2050F Figure 20: Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014Figure 21: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-
2020FFigure 22: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-
2020FFigure 23: Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-
2020FFigure 24: Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020FFigure 25: Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020FFigure 26: UK Dementia Market, By Type, 2014 (%)Figure 27: UK Dementia Cost, By Type of Service, 2014 (%)Figure 28: Number of Unpaid Caregivers (In Million)Figure 29: Pfizer Revenue (USD Million) AY 2011-2014Figure 30: Pfizer Percentage Revenue, By Business Segment (2014)Figure 31: Pfizer Percentage Revenue, By Geography (2014)
6
(c) AZOTH Analytics
List of FiguresFigure No. Title Page No.Figure 32: Novartis International AG Revenue (USD Million) AY 2011-2014Figure 33: Novartis International AG Percentage Revenue, By Business Segment (2014)Figure 34: Novartis International AG Percentage Revenue, By Geography (2014)Figure 35: Axovant Services Ltd. Revenue (USD Million) FY 2011-2015Figure 36: Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)Figure 37: Axovant Services Ltd. Percentage Revenue, By Geography (2014)Figure 38: Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014Figure 39: Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)Figure 40: Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)Figure 41: Biotie Therapies Revenue (USD Million) AY 2011-2014Figure 42: Biotie Therapies Percentage Revenue, By Business Segment (2014)Figure 43: Sales Comparatives, Top 5 Companies, 2011-2014Figure 44: EBITDA Comparatives, Top 5 Companies, 2011-2015Figure 45: EBIT Comparatives, Top 5 Companies, 2011-2015Figure 46: PBT Comparatives, Top 5 Companies, 2011-2015Figure 47: PAT Comparatives, Top 5 Companies, 2011-2015Figure 48: Current Ratio Comparatives, Top 5 Companies, 2011-2015Figure 49: Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015Figure 50: Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015
7
(c) AZOTH Analytics
Research Methodology
Research Definition
•Global Alzheimer’s disease Market Report comprises of the study of various aspects of Alzheimer’s Market and
forecast until 2020. The Alzheimer Disease Market has been segmented on basis of type of disease and type of
medical ailment and on regional basis globally.
Data Analysis and Interpretation
•Our historic market trend has been figured out by various paid databases which was further triangulated with various
secondary research sources along with primary interviews with the industry professionals/experts. Back-of-the-
Envelope calculation for the market estimation has been made through proper understanding of the market as well as
future business strategies of the companies involved in the market.
Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market
segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by
reaching out industry experts across the Alzheimer’s disease market.
For Forecasting purposes, we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, and Hoovers.
Companies ContactedPfizer Inc., Novartis International AG, Axovant Sciences Ltd.,Acadia Pharmaceuticals, Biotie Therapies
8
(c) AZOTH Analytics
Alzheimer’s Disease Market Overview
9
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
xxxx xx xx xx xx xx xx xx xx xx xxxx xx xx xx xx xx xx xx xx xx xx xx
Market Value Number of Patients
Figure 1: Global Alzheimer’s Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in
Million) 2010-2020F
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
xx xx xx xx xx xx xx xx xx xx xxFigure 2: Global Alzheimer’s Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
(c) AZOTH Analytics
Alzheimer’s Disease Market Overview
10
xx
xxxx
xxDisease Modifying Therapeutics
Diagonistics and Bio Markers
Imaging Sector
Therapeutics for treatment of symtoms
Figure 3: Global Alzheimer’s Market share, By
Therapeutics
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
xx xx xx xx xx xx xx xx xx xx xx
Figure 9: Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of
Patients in Million) 2010-2020F
xx
xxxx
xx
xx
Asia Pacific America's Europe Africa Row
Figure 3: Global Alzheimer’s Market share, By Region,
2014(In %)
(c) AZOTH Analytics
Alzheimer’s Disease Market Overview
11
2010 2011 2012 2013 20140%2%4%6%8%
10%12%14%
xxxx
xxxx
xxxx
xxxx
xxxx
xxxx
xxxx
xxxx
xxxx
xxxx
Medicare Medicade Out of Pocket Other
Figure 11: Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
0.0010.0020.0030.0040.0050.0060.00
xx xx xx xx xx xx xx xx xx Xx
Figure 15: U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013
(c) AZOTH Analytics
Alzheimer’s Disease Market Overview
12
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
xxxx xx xx xx xx xx xx xx xx xxxx xx xx xx xx xx xx xx xx xx xx
Number of Patients Value of the market
Figure 17: Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In
Million) 2010-2020F
xxxx
xxxx
Figure 17: Global Dementia Disease Market Size , By
Volume (Number of Patients In Million), By Region
2014
xxxx
xxxx
Figure 18: Global Dementia Disease Market Size , By
Number of new cases, By Volume (Number of Patients
In Million), By Region 2014
(c) AZOTH Analytics
Alzheimer’s Disease Market Overview
13
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
xx xx xx xx xx xx xx xx xx xx xx
Figure 22: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)
2010-2020F
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
xx xx xx xx xx xx xx xx xx xx xx
Figure 22: Global Dementia Disease Market Size High Income Countries ,Volume (Number of Patients In Million)
2010-2020F
(c) AZOTH Analytics
Alzheimer’s Disease Market Overview
14
China US India Japan Brazil Germany Russia Italy Indonesia France
xxxx xx xx
xx xx xx xx xx xx
Figure 23: Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-
2020F
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
xxxx xx xx xx xx xx xx xx xx xx
Figure 24: Australia Dementia Disease Market Size , By Volume
(Number of Patients In Million) 2010-2020F
Alzheimer's Disease Vascular Dementia Mixed Dementia Dementia with Lewy Bodies Frontotem-poral Demen-tia Parkinson's Dementia OthersSource: Azoth Analytics
Figure 26: UK Dementia Market, By
Type, 2014 (%)
(c) AZOTH Analytics
Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020)(By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)
Number of Pages: 106Price: US$ 2000 (Single User)Price: US$ 3000 (Multi-User)
Order Online: http://www.azothanalytics.com/report/global-alzheimer%E2%80%99s-drug-market-trends-opportunities-and-forecasts-2015-2020-r4
Contact Details
Contact Person: Subhodeep SenE-mail: [email protected] Number: Tel: +91 120 429 823524/7 Helpline Number: +91 9873 4262 88
About Azoth Analytics Pvt Ltd.Our business research and market analysis helps organizations across different industry verticals solve their business problems. In our reports, historic market trend is figured out by various paid databases which is further triangulated with inputs and insights from industry experts through primary research. Back-of-the-Envelope calculation for the market estimation is being made through proper understanding of the market as well as future business strategies of the companies engaged in the market. Our detailed research reports help our clients and customers get clear understanding of a specific industry or vertical of a designated country or region and make informed decision pertaining to market entry or expansion, strategic alliances or partnerships, product launch or brand positioning.
15
